Osmotherapy for intracranial hypertension: Mannitol versus hypertonic saline

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 3, 2012, Pages 640-654

  Fink, Matthew E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; MANNITOL; POTASSIUM CHLORIDE; SODIUM; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN PERFUSION; CENTRAL PONTINE MYELINOLYSIS; COMPARATIVE EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DEHYDRATION; DRUG EFFICACY; HEART ARRHYTHMIA; HEART OUTPUT; HEMOLYSIS; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; KIDNEY FAILURE; LUNG EDEMA; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; OSMOLALITY; OSMOTIC PRESSURE; PERFUSION PRESSURE; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; SERUM OSMOLARITY; SODIUM BLOOD LEVEL; TRAUMATIC BRAIN INJURY; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ACUTE KIDNEY INJURY; BRAIN EDEMA; CLINICAL TRIALS AS TOPIC; CRITICAL CARE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERNATREMIA; INTRACRANIAL HYPERTENSION; MANNITOL; OSMOLAR CONCENTRATION; PRACTICE GUIDELINES AS TOPIC; SALINE SOLUTION, HYPERTONIC;

EID: 84862172675     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000415432.84147.1e     Document Type: Review

References (44)

1. Mariano GSL, Fink ME, Hoffman C, Rosengart AJ. Intracranial pressure: Monitoring and management. In: Hall J, Schmidt G, Wood L, editors. Principles of critical care. 4th ed. New York, NY: McGraw-Hill, 2012.
2. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, AANS/CNS Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. 3rd ed. www.braintrauma.org/pdf/protected/Guidelines-Management-2007w-bookmarks. pdf. Accessed April 12, 2012.
3. Clausen T, Bullock R. Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 2001;7(15):1519.
4. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007;24(suppl 1):S14-S20.
5. Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep 2007;7(6):513-521.
6. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38(6):2001-2023.
7. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus 2007;22(5):E1.
8. Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab 2006;26(7): 951-958.
9. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004;39(2):464-470.
10. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002;33(1):136-140.
11. Garcia-Morales EF, Cariappa R, Parvin CA, et al. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004; 32(4):986-991.
12. Mariano GSL, Fink ME, Hoffman C, et al. Intracranial pressure: Monitoring and management. In: Hall J, Schmidt G, Wood L, editors. Principles of critical care. 4th ed. New York, NY: McGraw Hill, 2012.
13. Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007;1:CD001049.
14. Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials. Crit Care Med 2011;39(3):554-559.
15. Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: Use among neurointensivists. Neurocrit Care 2011;14(2):222-228.
16. Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: Literature review with meta-analysis. J Neurosurg 2012;116(1): 210-221.
17. Muizelaar JP, Wei EP, Kontos HA, Becker DP. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983;59(5):822-828.
18. Burke AM, Quest DO, Chien S, Cerri C. The effects of mannitol on blood viscosity. J Neurosurg 1981;55(4):550-553.
19. Mendelow AD, Teasdale GM, Russell T, et al. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985;63(1):43-48.
20. Sorani MD, Morabito D, Rosenthal G, et al. Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system. J Neurotrauma 2008;25(4):291-298.
21. Sorani MD, Manley GT. Dose-response relationship of mannitol and intracranial pressure: A metaanalysis. J Neurosurg 2008; 108(1):80-87.
22. Scalfani MT, Dhar R, Zazulia AR, et al. Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury [published ahead of print]. J Crit Care 2011; doi:10.1016/j.jcrc.2011.10.008.
23. Mirski AM, Denchev ID, Schnitzer SM, Hanley FD. Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J Neurosurg Anesthesiol 2000;12(4):334-344.
24. Qureshi AJ, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: Comparison between mannitol and hypertonic saline. Neurosurgery 1999;44(5): 1055-1063; discussion 1063-1064.
25. Cruz J, Minoja G, Okuchi K. Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal papillary widening: A randomized trial. Neurosurgery 2002;51(3):628-637; discussion 637-638.
26. Koenig MA, Bryan M, Lewin JL III, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008;70(13): 1023-1029.
27. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992;77(4):584-589.
28. McManus ML, Soriano SG. Rebound swelling of astroglial cells exposed to hypertonic mannitol. Anesthesiology 1998;88(6): 1586-1591.
29. Sankar T, Assina R, Karis JP, et al. Neurosurgical implications of mannitol accumulation within a meningioma and its peritumoral region demonstrated by magnetic resonance spectroscopy: Case report. J Neurosurg 2008;108(5):1010-1013.
30. Palma L, Bruni G, Fiaschi AI, Mariottini A. Passage of mannitol into the brain around gliomas: A potential cause of rebound phenomenon. A study on 21 patients. J Neurosurg Sci 2006;50(3):63-66.
31. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 1990;69(3):153-159.
32. Visweswaran P, Massin EK, Dubose TD Jr. Mannitol-induced renal failure. J Am Soc Nephrol 1997;8(6):1028-1033.
33. Weaver A, Sica DA. Mannitol-induced acute renal failure. Nephron 1987;45(3):233-235.
34. Prough DS, Whitley JM, Taylor CL, et al. Rebound intracranial hypertension in dogs after resuscitation with hypertonic solutions from hemorrhagic shock accompanied by an intracranial mass lesion. J Neurosurg Anesthesiol 1999;11(2):102-111.
35. Oddo M, Levine JM, Frangos S, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry 2009;80(8):916-920.
36. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003;31(6):1683-1687.
37. Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998;26(6):1118-1122.
38. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998;26(3):440-446.
39. Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: How high is too high? J Crit Care 2006;21(2):163-172.
40. Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med 2009;37(4):1433-1441.
41. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005;33(1):196-202; discussion 257-258.
42. Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36(3):795-800.
43. Zeng HK, Wang QS, Deng YY, et al. A comparative study on the efficacy of 10% hypertonic saline and equal volume of 20% mannitol in the treatment of experimentally induced cerebral edema in adult rats. BMC Neurosci 2010;11:153.
44. da Silva JC, de Lima FMT, Valenca MM, et al. Hypertonic saline more efficacious than mannitol in lethal intracranial hypertension model. Neurol Res 2010;32(2):139-143.